The impact of alpha-1 antitrypsin augmentation therapy on neutrophil-driven respiratory disease in deficient individuals

The impact of alpha-1 antitrypsin augmentation therapy on neutrophil-driven respiratory disease in deficient individuals

Danielle M Dunlea, Laura T Fee, Thomas McEnery, Noel G McElvaney, Emer P Reeves Irish Centre for Genetic Lung Disease, Department of Medicine, Royal College of Surgeons in Ireland, Beaumont Hospital, Dublin, Ireland Abstract: Alpha-1 antitrypsin (AAT) is the most abundant serine protease inhibitor c...

Full description

Bibliographic Details
Main Authors: Dunlea DM, Fee LT, McEnery T, McElvaney NG, Reeves EP
Format: Article
Language:English
Published: Dove Medical Press 2018-03-01
Series:Journal of Inflammation Research
Subjects:
Neutrophils
alpha-1 antitrypsin deficiency
alpha-1 antitrypsin augmentation
inflammation
airways disease
Online Access:https://www.dovepress.com/the-impact-of-alpha-1-antitrypsin-augmentation-therapy-on-neutrophil-d-peer-reviewed-article-JIR

Internet

https://www.dovepress.com/the-impact-of-alpha-1-antitrypsin-augmentation-therapy-on-neutrophil-d-peer-reviewed-article-JIR

Similar Items